Komori
M3 (2413) · PolicyAdvanced

Holding Shares for Collaboration and Periodically Verifying Their Rationale

First written in FY2019. 5 of 8 entries say "Advanced", first in FY2022. Latest entry: FY2026.

8entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY2021AdvancedFY2022 – FY20262019: 120192020: 120202021: 120212022: 120222023: 120232024: 120242025: 120252026: 12026
Same theme, other companies
Review of the Rationale for Holding Strategic ShareholdingsA theme 1297 companies write about · 1 as a headwind · 690 as a tailwind

106 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 200 companies compared. The sentences above are computed from all 200.Comparing 200 of the theme's 1301 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「非上場株式 40 4,178 非上場株式以外の株式 5 1,557」

    協業を目的とする株式保有と合理性検証の方針を継続し、保有銘柄は非上場株式40銘柄、非上場株式以外5銘柄となった。非上場株式4銘柄に新規投資する一方、非上場株式以外の株式5銘柄を売却した。
  2. FY2025AdvancedAnnual report

    「非上場株式 38 3,674 非上場株式以外の株式 10 2,294」

    協業を目的とする株式保有と合理性検証の方針を継続し、保有銘柄は非上場株式38銘柄、非上場株式以外10銘柄となった。非上場株式6銘柄への新規投資と、上場株式2銘柄の売却も開示している。
  3. FY2024AdvancedAnnual report

    「各銘柄の当初の保有の目的が達成された、もしくは達成が見込まれないと判断された場合は取締役会等で株式の売却について決議し、適宜・適切に売却します。」

    協業を目的とする株式保有と合理性検証の方針を継続し、保有銘柄は非上場株式34銘柄、非上場株式以外11銘柄となった。新規投資は非上場株式3銘柄、非上場株式以外2銘柄で、売却も実施した。
  4. FY2023AdvancedAnnual report

    「各銘柄の当初の保有の目的が達成された、もしくは達成が見込まれないと判断された場合は取締役会等で株式の売却について決議し、適宜・適切に売却します。」

    協業を目的とする株式保有と合理性検証の方針を継続し、当期は非上場株式33銘柄、非上場株式以外8銘柄を保有した。非上場株式6銘柄への新規投資と、複数銘柄の売却も開示している。
  5. FY2022AdvancedAnnual report

    「各銘柄の当初の保有の目的が達成された、もしくは達成が見込まれないと判断された場合は取締役会等で株式の売却について決議し、適宜・適切に売却します。」

    協業を目的とする株式保有と合理性検証の方針を継続し、当期は非上場株式30銘柄、非上場株式以外8銘柄を保有し、非上場株式6銘柄への新規投資を開示した。
  6. FY2021RestatedAnnual report

    「As a general principle, we invest in shares of counterpart companies when collaboration is expected to increase the corporate value of both our Company and the counterparty. We obtain information on counterpart companies as appropriate and periodically assess whether the original purpose of the holdings has been achieved, thereby verifying the rationale for continuing to hold them.」

    協業を目的とする株式保有と、保有目的・合理性の定期検証を継続している。
  7. FY2020RestatedAnnual report

    「As a general principle, we invest in shares of counterpart companies when collaboration is expected to increase the corporate value of both our Company and the counterparty. We obtain information on counterpart companies as appropriate and periodically assess whether the original purpose of the holdings has been achieved, thereby verifying the rationale for continuing to hold them.」

    協業を目的とする株式保有と、保有目的・合理性の定期検証を継続している。
  8. FY2019First statedAnnual report

    「As a general principle, we invest in shares of counterpart companies when collaboration is expected to increase the corporate value of both our Company and the counterparty. We obtain information on counterpart companies as appropriate and periodically assess whether the original purpose of the holdings has been achieved, thereby verifying the rationale for continuing to hold them.」

    The Company discloses a policy of holding shares to enhance corporate value through collaboration and periodically assessing whether the purpose and rationale for each holding remain valid.
Moved together

"Improving Medium- to Long-Term Performance and Promoting Shareholder-Oriented Management Through Share-Based Compensation" moved the same way as this thread, in the same document, in 5 of its 8 moves.

555544★123456
  1. ★This thread
  2. 1Improving Medium- to Long-Term Performance and Promoting Shareholder-Oriented Management Through Share-Based Compensation5×
  3. 2Realizing Growth Through Alliances, Acquisitions and Capital Investments5×
  4. 3Enhancing the Value of m3.com and Expanding the Healthcare Professional Member Base5×
  5. 4Recruiting and Developing Entrepreneurial Talent5×
  6. 5Expansion and Growth Investment in the Career Solutions Business4×
  7. 6Expanding Medical-Institution Support and Home-Visit Nursing Businesses4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
M3's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.